Task: Answer the multiple-choice question.
Query: Which drug exhibits a 0.201% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a. CCN(CC)C(=O)CSc1ncnc2sccc12
b. Brc1cccc(CNCC2CCCO2)c1
c. Cc1ccc(S(=O)(=O)N(Cc2cccc(F)c2)C(=O)N2CCN(C)CC2)cc1
d. Cc1ccc(/C=N/NC(=O)c2cc(C)oc2C)cc1
Answer: a. CCN(CC)C(=O)CSc1ncnc2sccc12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN(CC)C(=O)CSc1ncnc2sccc12
CCN(CC)C(=O)CSc1ncnc2sccc12
N,N-diethyl-2-thieno[2,3-d]pyrimidin-4-ylsulfanylacetamide